Vascular endothelium viability and function after total cardiopulmonary bypass in neonatal piglets

American Journal of Respiratory and Critical Care Medicine

Volumn 159, Issue 2, 1999, Pages 544-551

  Serraf, Alain ^a   Sellak, Hassan ^b   Hervé, Philippe ^b   Bonnet, Nicolas ^b   Robotin, Monica ^b   Detruit, Hélène ^b   Baudet, Bruneau ^b   Mazmanian, Guy Michel ^b   Planche, Claude ^b  

^a CENTRE CHIRURGICAL MARIE LANNELONGUE   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

MYELOPEROXIDASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; BLOOD VESSEL FUNCTION; CARDIOPULMONARY BYPASS; CELL ADHESION; CELL VIABILITY; CYTOTOXICITY; ENZYME ACTIVITY; GAS EXCHANGE; LEUKOCYTE ACTIVATION; LUNG HEMODYNAMICS; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY; REPERFUSION; SWINE; VASCULAR ENDOTHELIUM;

EID: 0033048387     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.159.2.9803024     Document Type: Article

References (31)

1. Wessel, D. L., I. Adatia, T. M. Giglia, J. E. Thompson, and T. J. Kulik. 1993. Use of inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardiopulmonary bypass. Circulation 88(Pt. 1):2128-2138.
2. Haslam, P., P. Townsend, and M. Branthwaite. 1980. Complement activation during cardiopulmonary bypass. Anaesthesia 25:22-26.
3. Chenoweth, D. E., S. W. Cooper, T. E. Hugli, R. W. Stewart, E. H. Blackstone, and J. W. Kirklin. 1981. Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins. N. Engl. J. Med. 304:497-503.
4. Rinder, C., J. Bonnert, H. Rinder, J. Michell, K. Ault, and R. Hillman. 1991. Platelet activation and aggregation during cardiopulmonary bypass. Anesthesiology 74:388-393.
5. Braude, S., K. B. Nolop, J. S. Fleming, T. Krausz, K. M. Taylor, and D. Royston. 1986. Increased pulmonary transvascular protein flux after canine cardiopulmonary bypass: association with lung neutrophil sequestration and tissue peroxidation. Am. Rev. Respir. Dis. 134:867-872.
6. Parker, D. J., J. W. Cantrell, R. B. Karp, R. M. Stroud, and S. B. Digerness. 1972. Changes in serum complement and immunoglobulins following cardiopulmonary bypass. Surgery 71:824-827.
7. Colman, R. W. 1990. Platelet and neutrophil activation in cardiopulmonary bypass. Ann. Thorac. Surg. 49:32-34.
8. Dreyer, W. J., L. H. Michael, E. E. Millman, K. L. Berens, and R. S. Geske. 1995. Neutrophil sequestration and pulmonary dysfunction in a canine model of open heart surgery with cardiopulmonary bypass: evidence for a CD18-dependent mechanism. Circulation 92:2276-2283.
9. Hind, C. R. K., J. F. Griffin, S. Pack, Y. E. Latchman, H. F. Drake, H. M. John, J. Brostoft, T. L. Dormandy, and T. Treasure. 1988. Effect of cardiopulmonary bypass on circulating concentrations of leucocyte elastase and free radical activity. Cardiovasc. Res. 22:37-41.
10. Faymonville, M. E., J. Pincemail, J. Duchateau, J. M. Paulus, A. Adam, G. Deby-Dupont, C. Deby, A. Albert, R. Larbuisson, and R. Limel. 1991. Mycloperoxidase and elastase as markers of leukocyte activation during cardiopulmonary bypass in humans. J. Thorac. Cardiovasc. Surg. 102:309-317.
11. Shafique, T., R. G. Johnson, H. B. Dai, R. M. Weintraub, and F. W. Selke. 1993. Altered pulmonary microvascular reactivity after total cardiopulmonary bypass. J. Thorac. Cardiovasc. Surg. 106:479-486.
12. Kirshbom, P. M., M. T. Jacobs, S. S. L. Tsui, L. R. DiBernardo, D. A. Schwinn, R. M. Ungerleider, and J. W. Gaynor. 1996. Effects of cardiopulmonary bypass and cirulatory arrest on endothelium dependent vasodilation in the lung. J. Thorac. Cardiovasc. Surg. 111:248-256.
13. Serraf, A., M. Robotin, N. Bonnet, H. Détruit, B. Baudet, M. Mazmanian, P. Hervé, and C. Planché. 1997. Alteration of the neonatal pulmonary physiology following total cardiopulmonary bypass. J. Thorac. Cardiovasc. Surg. 114:1006-1009.
14. Mullane, K. M., R. Kraemer, and B. Smith. 1985. Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration in ischemic myocardium. J. Pharmacol. Methods 14:157-167.
15. Liu, S. F., A. A. Hislop, S. G. Haworth, and J. P. Barnes. 1992. Developmental changes in endothelium dependent pulmonary vasorelaxation. Br. J. Pharmacol. 106:324-330.
16. Visner, G. A., E. D. Stapes, S. E. Chesrown, E. R. Block, D. S. Zander, and H. S. Nick. 1994. Isolation and maintenance of human pulmonary artery endothelial cells in culture isolated from human pulmonary artery from transplant donors. Am. J. Physiol. 267:L406-L413.
17. Sellak, H., E. Franzini, J. Hakim, and C. Pasquier. 1994. Reactive oxygen species rapidly increase endothelial ICAM-1 ability to bind neutrophils without detectable upregulation. Blood 83:2669-2677.
18. Perianin, A., M. A. Gougerot-Pocidalo, J. P. Giroud, and J. Hakim. 1987. Diclofenac binding to human polymorphonuclear neutrophils: effect of respiratory burst and N-formylated peptide binding. Biochem. Pharmacol. 36:2609-2614.
19. Kirklin, J. K., S. Westaby, E. H. Blackstone, J. W. Kirklin, D. E. Chenoweth, and A. D. Pacifico. 1983. Complement and damaging effects of cardiopulmonary bypass. J. Thorac. Cardiovasc. Surg. 86:845-857.
20. Hattori, R., K. K. Hamilton, R. D. Fugate, R. P. McEver, and J. P. Sims. 1989. Complement protein C5B-9 induce secretion of high molecular weight multimers of endothelial von Willebrand factor and translocation of granule membrane protein GMP-140 to the cell surface. J. Biol. Chem. 264:9053-9060.
21. Finn, A., and W. J. Dreyer. 1993. Neutrophil adhesion and the inflammatory response induced by cardiopulmonary bypass. Cardiology in the Young 3:244-250.
22. Bishop, M. J., W. Lamm, S. M. Guidotti, and R. K. Albert. 1992. Pulmonary artery occlusion is sufficient to increase pulmonary vascular permeability in rabbits. J. Appl. Physiol. 73:272-275.
23. Normandin, L., P. Herve, C. Brink, A. R. Chapelier, P. G. Dartevelle, and G. M. Mazmanian. 1995. L-arginine and pentoxyfilline attenuate endothelial dysfunction after lung reperfusion injury in the rabbit. Ann. Thorac. Surg. 60:646-650.
24. Huk, I., J. Nanobashvili, C. Neumayer, A. Punz, M. Mueller, K. Afkhampour, M. Mittlboeck, U. Losert, P. Polterauer, E. Roth, S. Patton, and T. Malinski. 1997. L-arginine treatment alters the kinetics of nitric oxide and superoxide release and reduces ischemia/reperfusion injury in skeletal muscle. Circulation 96:667-675.
25. Shreeniwas, R., S. Koga, D. J. Pinsky, E. Kaiser, J. Brett, B. A. Wolitzky, C. Norton, J. Plocinski, and W. Benjamin. 1992. Hypoxia mediated induction of interleukin 1 alpha: an autocrine mechanism promoting expression of leukocyte adhesion molecules on the vessel surface. J. Clin. Invest. 90:2333-2339.
26. Karakurum, M., R. Shreeniwas, J. Chen, D. Pinsky, S. D. Yan, M. Anderson, K. Sunouchi, J. Malor, T. Hamilton, and K. Kuwabara. 1994. Hypoxic induction of interleukin 8 gene expression in endothelial cells. J. Clin. Invest. 93:1564-1570.
27. Pinsky, D. J., S. F. Yan, C. Lawson, Y. Naka, J. X. Chen, E. S. Connoly, and D. M. Stern. 1995. Hypoxia and modification of the endothelium: implications for regulation of vascular homeostatic properties. Semin. Cell Biol. 6:283-294.
28. Barbotin-Larrieu, F., M. Mazmanian, B. Baudet, H. Detruit, A. Chapelier, J. M. Libert, P. Dartervelle, and P. Hervé. 1996. Prevention of ischemia-reperfusion lung injury by inhaled nitric oxide in neonatal piglets. J. Appl. Physiol. 80:782-788.
29. Perry, S. W., L. G. Epstein, and H. A. Gelbard. 1997. Simultaneous in situ detection of apoptosis and necrosis in monolayer cultures by TUNEL and trypan blue staining. BioTechniques 22:1102-1106.
30. Lopez-Farré, A., S. M. Lourdes, C. Caramelo, J. Gomes-Macias, R. Garcia, J. R. Mosquera, T. DeFructos, I. Millas, F. Rivas, G. Echezarreta, and S. Casado. 1997. Role of nitric oxide in autocrine control of growth and apoptosis of endothelial cells. Am. J. Physiol. 272:H760-H768.
31. Burdon, R. H., V. Gill, and C. Rice-Evans. 1989. Cell proliferation and oxydative stress. Free Radic. Res. 7:149-159.